Vychytil A - Search Results

1

Riboflavin is a determinant of total homocysteine plasma concentrations in end-stage renal disease patients.

Skoupy S, Födinger M, Veitl M, Perschl A, Puttinger H, Röhrer C, Schindler K, Vychytil A, Hörl WH, Sunder-Plassmann G. Skoupy S, et al. Among authors: vychytil a. J Am Soc Nephrol. 2002 May;13(5):1331-7. doi: 10.1097/01.asn.0000013299.11876.f6. J Am Soc Nephrol. 2002. PMID: 11961021

2

New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography.

Vychytil A, Lorenz M, Schneider B, Hörl WH, Haag-Weber M. Vychytil A, et al. J Am Soc Nephrol. 1998 Feb;9(2):290-6. doi: 10.1681/ASN.V92290. J Am Soc Nephrol. 1998. PMID: 9527406 Clinical Trial.

3

New strategies to prevent Staphylococcus aureus infections in peritoneal dialysis patients.

Vychytil A, Lorenz M, Schneider B, Hörl WH, Haag-Weber M. Vychytil A, et al. J Am Soc Nephrol. 1998 Apr;9(4):669-76. doi: 10.1681/ASN.V94669. J Am Soc Nephrol. 1998. PMID: 9555670 Clinical Trial.

4

Major determinants of hyperhomocysteinemia in peritoneal dialysis patients.

Vychytil A, Födinger M, Wölfl G, Enzenberger B, Auinger M, Prischl F, Buxbaum M, Wiesholzer M, Mannhalter C, Hörl WH, Sunder-Plassmann G. Vychytil A, et al. Kidney Int. 1998 Jun;53(6):1775-82. doi: 10.1046/j.1523-1755.1998.00918.x. Kidney Int. 1998. PMID: 9607212 Free article.

5

Adrenal function in patients with chronic renal failure.

Clodi M, Riedl M, Schmaldienst S, Vychytil A, Kotzmann H, Kaider A, Bieglmayer C, Mayer G, Waldhäusl W, Luger A. Clodi M, et al. Among authors: vychytil a. Am J Kidney Dis. 1998 Jul;32(1):52-5. doi: 10.1053/ajkd.1998.v32.pm9669424. Am J Kidney Dis. 1998. PMID: 9669424

6

Tidal peritoneal dialysis for home-treated patients: should it be preferred?

Vychytil A, Lilaj T, Schneider B, Hörl WH, Haag-Weber M. Vychytil A, et al. Am J Kidney Dis. 1999 Feb;33(2):334-43. doi: 10.1016/s0272-6386(99)70309-4. Am J Kidney Dis. 1999. PMID: 10023647

7

Ultrasonography of the catheter tunnel in peritoneal dialysis patients: what are the indications?

Vychytil A, Lilaj T, Lorenz M, Hörl WH, Haag-Weber M. Vychytil A, et al. Am J Kidney Dis. 1999 Apr;33(4):722-7. doi: 10.1016/s0272-6386(99)70225-8. Am J Kidney Dis. 1999. PMID: 10196015

8

Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients.

Vychytil A, Födinger M, Papagiannopoulos M, Wölfl G, Hörl WH, Sunder-Plassmann G. Vychytil A, et al. Kidney Int. 1999 May;55(5):2054-61. doi: 10.1046/j.1523-1755.1999.00437.x. Kidney Int. 1999. PMID: 10231471 Free article.

9

Influence of the preceding exchange on peritoneal equilibration test results: a prospective study.

Lilaj T, Vychytil A, Schneider B, Hörl WH, Haag-Weber M. Lilaj T, et al. Among authors: vychytil a. Am J Kidney Dis. 1999 Aug;34(2):247-53. doi: 10.1016/s0272-6386(99)70351-3. Am J Kidney Dis. 1999. PMID: 10430970

10

A case of continuous ambulatory peritoneal dialysis peritonitis with an uncommon organism and an atypical clinical course.

Konner P, Watschinger B, Apfalter P, Hörl WH, Vychytil A. Konner P, et al. Among authors: vychytil a. Am J Kidney Dis. 2001 Jan;37(1):E10. doi: 10.1016/s0272-6386(01)90007-1. Am J Kidney Dis. 2001. PMID: 11136199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters